Mj. Heeb et al., Importance of individual activated protein C cleavage site regions in coagulation Factor V for Factor Va inactivation and for Factor Xa activation, EUR J BIOCH, 260(1), 1999, pp. 64-75
Activated protein C (APC) cleavage of Factor Va (FVa) at residues R-506 and
R-306 correlates With its inactivation. APC resistance and increased throm
botic risk are due to the mutation R506Q in Factor V (FV). To study the eff
ects of individual cleavages in FVa by APC and the importance of regions ne
ar the cleavage sites, the following recombinant (r) human FVs were prepare
d and purified: wild-type, Q(306)-rFV, Q(506)-rFV, and Q(306)Q(506)-rFV. Al
l had similar time courses for thrombin activation. Q(506)-rFVa was cleaved
by APC at R-306 and was moderately resistant to APC in plasma-clotting ass
ays and in prothrombinase assays measuring FVa residual activity, in agreem
ent with studies of purified plasma-derived Q(506)-FVa. Q(506)-rFVa was cle
aved by APC at R-306 and gave a low APC-resistance ratio similar to Q(506)-
rFVa in clotting assays, whereas unactivated Q(306)-rFV gave a near-normal
APC-resistance ratio. When FVa residual activity was measured after lone ex
posure to APC, Q(306)-rFVa was inactivated by only less than or equal to 40
% under conditions where Q(506)-rFVa was inactivated > 90%, supporting the
hypothesis that efficient inactivation of normal FVa by APC requires cleava
ge at R-306. In addition, the heavy chain of Q(306)-rFVa was cleaved at R-5
06 much more rapidly than activity was lost, suggesting that FVa cleaved at
only R-506 is partially active. Under the same conditions, Q(306)Q(506)-rF
Va lost no activity and was not cleaved by APC. Therefore, cleavage at eith
er R-506 or R-306 appears essential for significant inactivation of FVa by
APC. Modest loss of activity, probably due to cleavage at R-679, was observ
ed for the single site rFVa mutants, as evidenced by a second phase of inac
tivation. Q(306)Q(506)-rFVa had a low activity-to-antigen ratio of 0.50-0.7
7, possibly due to abnormal Factor Xa (FXa) binding. Furthermore, Q(306)Q(5
06)-rFV was very resistant to cleavage and activation by FXa. Q(306)Q(506)-
rFV appeared to bind FXa and inhibit FXa's ability to activate normal FV. T
hus, APC may downregulate FV/Va partly by impairing FXa-binding sites upon
cleavage at R-306 and R-506. This study shows that R-306 is th, most import
ant cleavage site for normal efficient inactivation of FVa by APC and suppo
rts Ether studies suggesting that regions near R-306 and R-506 provide FXa-
binding sites and that FVa cleaved at only R-506 retains partial activity.